Ohio State University has described NADH-ubiquinone oxidoreductase (complex I) inhibitors acting as radiosensitizers for radiation therapy reported to be useful for the treatment of cancer.
NADH dehydrogenase in light green; succinate dehydrogenase in dark green; the complex formed by acyl-CoA dehydrogenase, electron transfer flavoprotein (ETFP), and ETFP-ubiquinone oxidoreductase in ...
Longer distances can be covered within multi-protein systems such as Complex I (NADH:ubiquinone oxidoreductase) of the respiratory chain, comprising up to 14 subunits and 9 different clusters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback